On #WorldMalariaDay, we’re proud to reflect on the progress made through strong partnerships in the fight to eliminate #malaria.
In 2024, Thailand became the first country in the region to introduce single-dose tafenoquine as a tool to prevent relapses of #P. vivax malaria—a major milestone in elimination efforts. Since P. vivax parasites can remain dormant in the body and continue spreading, tackling this form of malaria is especially challenging. Tafenoquine offers a powerful solution.
This achievement was made possible through the ARCTIC study—a tafenoquine feasibility initiative supported by Thailand’s Ministry of Public Health and our partner, @Medicines for Malaria Venture. ARCTIC has expanded access to tafenoquine and positioned Thailand as a regional leader in the treatment of relapsing malaria, setting an example for others to follow.